WRN inhibitors sensitize cancer cells to topoisomerase inhibitors and to mitomycin C in FA cells that have defects in repair of interstrand crosslinks, suggesting that WRN may play a role in the repair of these types of lesions [196,197]. The gene discussed is WRN; the disease is cancer.